Figure 4From: Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer Probability of survival in the subgroup of patients submitted to hormonal therapy (n=151) according to PR expression using the current method with >10% cut-off A) RFS (P<0.001) and B) OS (P<0.001). Back to article page